FdaApplication
ANDA 212077
Identifiers
- fda_app_no: ANDA212077
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2022-08-01 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PIRFENIDONE | PIRFENIDONE | 267MG | CAPSULE;ORAL |
1 product